PCN21 - COMPARATIVE EFFICACY OF NIVOLUMAB±IPILIMUMAB VERSUS STANDARD OF CARE (SOC) FOR THIRD-LINE (3L) PATIENTS WITH RECURRENT SMALL CELL LUNG CANCER (SCLC) USING POPULATION-ADJUSTED INDIRECT COMPARISON
Abstract
Authors
S. Cope E. Popoff S. Keeping R. Goldgrub J.P. Jansen J.R. Penrod P. Abraham D.R. Camidge B. Korytowsky T. Gu N. Schoenherr A. Juarez-Garcia T. Le Y. Yuan